HUP0002442A2 - Heterociklusos tio-észterek nitrogénen át kapcsolódó karbamid- és karbamátszármazékai, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Heterociklusos tio-észterek nitrogénen át kapcsolódó karbamid- és karbamátszármazékai, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0002442A2
HUP0002442A2 HU0002442A HUP0002442A HUP0002442A2 HU P0002442 A2 HUP0002442 A2 HU P0002442A2 HU 0002442 A HU0002442 A HU 0002442A HU P0002442 A HUP0002442 A HU P0002442A HU P0002442 A2 HUP0002442 A2 HU P0002442A2
Authority
HU
Hungary
Prior art keywords
optionally
group
substituted
heterogroup
heteroatom
Prior art date
Application number
HU0002442A
Other languages
English (en)
Inventor
Gregory S. Hamilton
Wei Huang
Jia-He Li
Original Assignee
Guilford Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharmaceuticals Inc. filed Critical Guilford Pharmaceuticals Inc.
Publication of HUP0002442A2 publication Critical patent/HUP0002442A2/hu
Publication of HUP0002442A3 publication Critical patent/HUP0002442A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Abstract

A találmány (I) általános képletíí vegyületekre vonatkozik, aképletben A és B jelentése a kapcsolódó nitrogénatommal és szénatommalegyütt 5-7 tagú telített vagy telítetlen heterociklusos gyűrű, amelyCH2, O, S, SC, SO2, NH vagy NR3 tetszőleges kombinációját tartalmazza,X jelentése oxigénatom vagy kénatom, Y jelentése közvetlen kötés, vagyalkilcsoport vagy alkenilcsoport, amelyek adott esetben szubsztituálvalehetnek, vagy adott esetben heteroatomot vagy heterocsoportottartalmazhatnak, Z jelentése közvetlen kötés vagy alkilcsoport vagyalkenilcsoport, amelyek adott esetben szubsztituálva lehetnek vagyheteroatomot vagy heterocsoportot tartalmazhatnak, C és D jelentéseegymástól függetlenül hidrogénatom, Ar vagy alkilcsoport vagyalkenilcsoport, amelyek adott esetben szubsztituálva lehetnek vagyheteroatomot vagy heterocsoportot tartalmazhatnak, ahol Ar jelentéseadott esetben szubsztituált arilcsoport vagy heteroarilcsoport, Wjelentése oxigénatom vagy kénatom, U jelentése oxigénatom vagynitrogénatom, ahol U = O esetben R1 jelentése egyedülálló elektronpárés R2 jelentése Ar, cikloalkilcsoport vagy alkilcsoport vagyalkenilcsoport, amelyek adott esetben szubsztituálva lehetnek, vagyheteroatomot vagy heterocsoportot tartalmazhatnak, és U = N esetben R1és R2 jelentése egymástól függetlenül hidrogénatom, Ar2cikloalkilcsoport vagy alkilcsoport vagy alkenilcsoport, amelyek adottesetben szubsztituálva lehetnek vagy heteroatomot vagy heterocsoportottartalmazhatnak. A találmány kiterjed a fenti vegyületeket tartalmazógyógyszerkészítményekre. A találmány szerinti vegyületek előnyösenalkalmazhatók neurodegeneratív betegségben szenvedő betegeknél aneurodegeneráció megelőzésére. Ó
HU0002442A 1996-12-31 1997-12-23 N-linked ureas and carbamates of heterocyclic thioesters and pharmaceutical compositions containing them HUP0002442A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/775,585 US5935989A (en) 1996-12-31 1996-12-31 N-linked ureas and carbamates of heterocyclic thioesters

Publications (2)

Publication Number Publication Date
HUP0002442A2 true HUP0002442A2 (hu) 2000-12-28
HUP0002442A3 HUP0002442A3 (en) 2001-01-29

Family

ID=25104858

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002442A HUP0002442A3 (en) 1996-12-31 1997-12-23 N-linked ureas and carbamates of heterocyclic thioesters and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (2) US5935989A (hu)
KR (1) KR20000057488A (hu)
AR (1) AR013909A1 (hu)
AU (1) AU721572B2 (hu)
BG (1) BG103408A (hu)
BR (1) BR9714092A (hu)
CA (1) CA2239781A1 (hu)
CZ (1) CZ154699A3 (hu)
GT (1) GT199800014A (hu)
HU (1) HUP0002442A3 (hu)
IL (1) IL129696A0 (hu)
PA (1) PA8444001A1 (hu)
PL (1) PL334372A1 (hu)
WO (1) WO1998029117A1 (hu)
ZA (1) ZA9711704B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
AU764073B2 (en) * 1997-06-04 2003-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
KR20010052502A (ko) * 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 Ｎ-헤테로사이클릭 카복실산 및 카복실산 등입체의 요소및 카르밤산염
ATE268772T1 (de) 1998-07-17 2004-06-15 Agouron Pharma Verbindungen und zusammensetzungen um neurales wachstum und streckung zu stimulieren
US6399648B1 (en) * 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6506788B1 (en) * 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6337340B1 (en) * 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US7265150B1 (en) * 1998-08-14 2007-09-04 Gpi Nil Holdings Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU5606400A (en) 1999-07-09 2001-01-30 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
AU5483500A (en) 1999-07-09 2001-01-30 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
BR0012327A (pt) * 1999-07-09 2002-07-02 Ortho Mcneil Pharm Inc Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
CO5261615A1 (es) 1999-12-01 2003-03-31 Agouron Pharma Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
KR20200089219A (ko) * 2019-01-15 2020-07-24 보로노이 주식회사 아릴 또는 헤테로아릴 유도체, 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310461A (en) * 1980-06-23 1982-01-12 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4578474A (en) * 1980-06-23 1986-03-25 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4390695A (en) * 1980-06-23 1983-06-28 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4596819A (en) * 1984-01-23 1986-06-24 Warner-Lambert Company Modified tripeptides
US4593102A (en) * 1984-04-10 1986-06-03 A. H. Robins Company, Inc. N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-position
GB2182938B (en) * 1985-11-13 1989-11-08 Otsuka Pharma Co Ltd Antihypertensive proline peptides
US5001142A (en) * 1989-07-19 1991-03-19 American Cyanamid Company 1-substituted-2-(3-amino-1-propynyl)pyrrolidine derivatives
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
ATE183178T1 (de) * 1991-05-09 1999-08-15 Vertex Pharma Neue immunsuppressive verbindungen
MX9202466A (es) * 1991-05-24 1994-06-30 Vertex Pharma Compuestos inmunosupresores novedosos.
HU211101B (en) * 1992-03-13 1995-10-30 Egyt Gyogyszervegyeszeti Gyar Process for preparing 1-[/2s/-methyl-3-mercapto-propionyl]-pyrrolidine-/2s/-carboxylic acid
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5385918A (en) * 1993-02-09 1995-01-31 Miles Inc. Aminomethylene-peptides as immunosuppressants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
DE69512220T2 (de) * 1994-03-07 2000-03-16 Vertex Pharma Sulfonamidderivate als aspartylprotease-inhibitoren
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5726184A (en) * 1995-05-19 1998-03-10 Vertex Pharmaceuticals Incorporated Tetralin compounds with improved MDR activity
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds

Also Published As

Publication number Publication date
KR20000057488A (ko) 2000-09-15
BG103408A (en) 2000-01-31
AU5724198A (en) 1998-07-31
AR013909A1 (es) 2001-01-31
ZA9711704B (en) 1998-09-23
GT199800014A (es) 1999-07-13
BR9714092A (pt) 2000-05-09
AU721572B2 (en) 2000-07-06
CZ154699A3 (cs) 1999-11-17
PL334372A1 (en) 2000-02-28
CA2239781A1 (en) 1998-06-30
IL129696A0 (en) 2000-02-29
US6184243B1 (en) 2001-02-06
US5935989A (en) 1999-08-10
WO1998029117A1 (en) 1998-07-09
HUP0002442A3 (en) 2001-01-29
PA8444001A1 (es) 2000-05-24

Similar Documents

Publication Publication Date Title
HUP0002442A2 (hu) Heterociklusos tio-észterek nitrogénen át kapcsolódó karbamid- és karbamátszármazékai, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
NO305861B1 (no) N-acylsulfaminsyre-estere -tioestere, N-acylsulfonamider og N-sulfonyl-karbaminsyre-estere, -tioestere og farmas°ytisk preparat inneholdende disse forbindelsene
HUP0303037A2 (hu) Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
HUP0001232A2 (hu) Béta-amiloid peptid kibocsátást és/vagy szintézist gátló cikloalkil-, laktám-, laktonszármazékok, és ezek tio-analógjai, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP0004259A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények
ATE383858T1 (de) Substituierte tetrhydroisochinolin-derivate zur behandlung von entzündlichen erkrankungen
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
DK0696585T3 (da) Nyt bisoxadiazolidinderivat
ATE385496T1 (de) Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel
DK0998471T3 (da) Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
SE8303913D0 (sv) Heterocykliska foreningar
HUP9900668A2 (hu) Szulfamidsavszármazékok, N-acil-szulfonamidok és szulfonil-karbamát-származékok alkalmazása lipoproteinszintet csökkentő gyógyászati készítmények előállítására
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
NO994764L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende disse
DK0904270T3 (da) Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler
HUP0002457A1 (hu) 4-Halogénezett szteroidszármazékok, eljárás előállításukra, ezek intermedierjei, és ezeket tartalmazó gyógyszerkészítmények
HUP0202647A2 (hu) Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
ATE22284T1 (de) 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.